Abstract
This article is aimed at providing a practical up-to-date review of the precipitating factors, diagnosis, management and secondary prevention of hyperglycemic emergencies (diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar state (HHS) to assist critical care physicians and hospitalists caring for these patients. Limitations of various guidelines include implementation in settings with an infrastructure different from that specified in the guidelines of a respective country, state, region or community. Appropriate individualized acute management of these conditions typically results in satisfactory clinical outcomes and may decrease the mortality rate from up to 20% in type 2 diabetics with hyperglycemic hyperosmolar state vs less than 2% in patients with DKA. DKA may be the first manifestation of type 1 diabetes and can also occur in type 2 diabetics depending on the state of insulin sufficiency/secretion. For type 1 diabetics, the transition period from adolescence to adulthood is particularly critical to prevent repetitive hospital admissions. Hyperglycemic emergencies are usually preventable but do depend on patient compliance and adherence as well as medical infrastructure. Patients of all ages should be both appropriately educated and assured continuous access to health care to prevent recurrences of these conditions.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Centers for Disease Control and Prevention (CDC), 2008 Number (in Thousands) of Hospital Discharges with Diabetic Ketoacidosis as First-Listed Diagnosis, United States, 1980–2005. Available online. http://www.cdc.gov/diabetes/statistics/dkafirst/diabetes_complications/fig1.htm. Accessed October 8, 2011.
MacLsaac RJ, Lee RY, McNeil KJ, et al, 2002 Influence of age on the presentation an outcome of acidotic and hyperosmolar diabetic emergencies. Intern Med J 32: 379–785.
Ennis ED, Kreisberg RA 2003 Diabetic ketoacidosis and the hyperglycemic hyperosmolar syndrome. In: LeRoith D, Taylor SI, Olefsky JM (eds) Diabetes Mellitus: A Fundamental and Clinical Text 3rd edn, Lippincott Williams & Wilkins, Philadelphia; pp, 627–641.
Isotani H, Asaka S, Kameoka K, et al, 1997 Hyperglycemic hyperosmolar syndrome associated with severe ketosis in Japanese woman. Horm Metab Res 29: 360–361.
Greco AV, Ghirlanda G, Altomonte L, et al, 1981 Somatostatin and insulin infusion in the management of diabetic ketoacidosis. Horm Metab Res 13: 310–314.
Nugent BW, 2005 Hyperosmolar hyperglycemic state. Emerg Med Clin North Am 23: 629–648.
Kitabchi AE, Miles JM, Umpierrez GE, et al, 2009 Hyperglycemic crisis in adult patients with diabetes. Diabetes Care 32: 1335–1343.
Kitabchi AE, Umpierrez GE, Murphy MB, et al, 2006 Hyperglycemic crises in adult patients with diabetes: a consensus statement from the American Diabetes Association. Diabetes Care 29: 2739–2748.
Morris LR, Kitabchi AE, 1980 Efficacy of low-dose insulin therapy for severely obtunded patients in diabetic ketoacidosis. Diabetes Care 3: 53–56.
Stoner GD, 2005 Hyperosmolar hyperglycemic state. Am Fam Physician 71: 1723–1730.
Matz R, 1999 Management of hyperosmolar hyperglycemic syndrome. Am Fam Physician 60: 1468–1476.
Kitabchi AE, Umpierrez GE, Murphy MB, et al, 2001 Management of hyperglycemic crisis in patients with diabetes. Diabetes Care 24: 131–153.
Wachtel TJ, Tetu-Mouraddjian LM, Goldman LD, et al, 1991 Hyperosmolarity and acidosis in diabetes mellitus: A three year experience in Rhode Island. J Gen Intern Med 6: 495–502.
Burris AS, 1986 Leukemoid reaction associated with severe diabetic ketosis. South Med J 79: 647–648.
Esper AM, Moss M, Martin GS, 2009 The effect of diabetes mellitus on organ dysfunction with sepsis: an epidemiological study. Crit Care 13: R18.
Powers WJ, 1981 Cerebrospinal fluid to serum glucose ratios in diabetes mellitus and bacterial meningitis. Am J Med 71: 217–220.
MassDevice staff, 2010 FDA investigates reports of insulin pump problems. Available online. https://doi.org/www.massdevice.com/news/fda-investigates-reports-insulinpump-problems. Accesses October 8, 2011.
Hoogma RP, Schumicki D, 2006 Safety of insulin glulisine when given by continuous subcutaneous infusion using an external pump in patients with type 1 diabetes. Horm Metab Res 38: 429–433.
Hunger-Dathe W, Braun A, Müller UA, et al, 2003 Insulin pump therapy in patients with type 1 diabetes mellitus: results of the nationwide quality circle in Germany (ASD) 1999–2000. Exp Clin Endoclinol Diabetes 111: 428–434.
Nair S, Yadav D, Pitchumoni CS, 2000 Association of diabetic ketoacidosis and acute pancreatitis: observations in 100 consecutive episodes of DKA. Am J Gastroenterol 95: 2795–2800.
Chase CW, Barker DE, Russell WL, et al, 1996 Serum amylase and lipase in the evaluation of acute abdominal pain. Am Surg 62: 1028–1033.
Yazici KM, Erbas T, Yazici AH, 1998 The effect of clozapine on glucose metabolism. Exp Clin Endocrinol Diabetes 106: 475–477.
Kitabchi, AE, Nyenwe EA, 2006 Hyperglycemic crisis in diabetes mellitus: Diabetic ketoacidosis and hyperosmolar state. Endocrinol Metab Clin North Am 35: 725–751.
Warner AE, Greene GS, Buchsbaum MS, et al, 1998 Diabetic ketoacidosis associated with cocaine use. Arch Intern Med 158: 1799–1802.
Evans EM, Nye F, Beeching NJ, et al, 2005 ‘Disappearing diabetes’ – resolution of apparent type 1 diabetes in a patient with AIDS and cytomegalovirus (CMV) infection. Diabet Med 22: 218–220.
Izumi K, 2009 Diabetic ketoacidosis with cytomegalovirus-associated colitis. Intern Med 48: 343–346.
Besson C, Jubault V, Viard JP, et al, 1998 Ketoacidosis associated with protease inhibitor therapy. AIDS 12: 1399–1400.
Kan VL, Nylen ES, 1999 Diabetic ketoacidosis in an HIV patient: A new mechanism of HIV protease-inhibitor-induced glucose intolerance. AIDS 13: 1987–1989.
Takarabe D, Rokukawa Y, Takahashi Y, et al, 2010 Autoimmune diabetes in HIV-infected patients on highly active antiretroviral therapy. J Clin Endocrinolol Metab 95: 4056–4060.
Argarawal M, Swartz R, 2000 Acute renal failure. Am Fam Physician 61: 2077–2088.
Lewington A, Kanagasundaram S, 2011 Clinical Practice Guidelines: Acute Kidney Injury. Available online. https://doi.org/www.renal.org/Libraries/Guidelines/Acute_Kidney_Injury_-_Final_Draft_08_January_2011.sflb.ashx Accessed October 8, 2011.
Eisenbarth GS, Polonsky KS, Buse JB 2008 Acute diabetic emergencies: Diabetic ketoacidosis. In: Kronenberg HM, Melmed S, Polonsky KS et al (eds). Williams Textbook of Endocrinology, 11th edn, Saunders Elsevier, Pennsylvania; pp, 1407–1416.
Vanholder R, De Smet R, Glorieux G, et al, 2003 Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 63: 1934–1943.
Watkins PJ, Smith JS, Fitzgerald MG, et al, 1969 Lactic acidosis in diabetes. Br Med J 1: 744–747.
Samlan SR, Jordan MT, Chan SB, et al, 2008 Tinitus as a measure of salicylate toxicity in the overdose setting. West J Emerg Med 9: 146–149.
Chyka PA, Erdman AR, Christianson G, et al, 2007 Salicylate poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol 45: 95–131.
Mégarbane B, Borron SW, Baud FJ, 2005 Current recommendations for treatment of severe toxic alcohol poisonings. Intensive Care Med 31: 189–195.
Brent J, 2010 Fomepizole for the treatment of pediatric ethylene and diethylene glycol, butoxyethanol, and methanol poisonings. Clin Toxicol 48: 401–406.
Eisenhut M, 2006 Causes and effects of hyperchloremic acidosis. Crit Care 10: 413.
Walmsley RN, White GH, 1985 Normal “anion gap” (hyperchloremic) acidosis. Clin Chem 31: 309–313.
Charles JC, Heilman RL, 2005 Metabolic acidosis. Hosp Physician 41: 37–42.
Walmsley RN, White GH, 1985 Normal “Anion Gap” (Hyperchloremic) Acidosis. Clin Chem 31: 309–313.
Emmett M, Narins R, 1997 Clinical use of the anion gap. Medicine (Baltimore) 56: 38–54.
Levetan CS, Salas JR, Wilets JF et al, 1995 Impact of endocrine and diabetes team consultation on hospital length of stay for patients with diabetes. Am J Med 99: 22–28.
Levetan CS, Passaro MD, Jablonski KA, et al, 1999 Effect of physician specialty on outcomes in diabetic ketoacidosis. Diabetes Care 22: 1790–1795.
Katz MA, 1973 Hyperglycemia induced hyponatremia – calculation of expected serum sodium depression. N Engl J Med 289: 843–844.
Hillier TA, Abbott RD, Barrett EJ, 1999 Hyponatraemia: evaluating the correction factor for hyperglycemia. Am J Med 106: 399–403.
Cowart SL, Stachura ME 1990 Glucosuria. In: Walker HK, Hall WD, Hurst JW (eds). Clinical Methods: The History, Physical, and Laboratory Examinations, 3rd edn, Butterworths, Boston; pp, 653–657.
Wyckoff J, Abrahamson MJ 2005 Diabetic ketoacidosis and hyperosmolar hyperglycemic state. In: Kahn CR, Weir GC, King GL et al (eds). Joslin’s Diabetes Mellitus, 14th edn, Lippincott Williams & Wilkins, Philadelphia; pp, 887–899.
Goyal N, Miller JB, Sankey SS, et al, 2010 Utility of initial bolus insulin in the treatment of diabetic ketoacidosis. J Emerg Med 38: 422–427.
Kitabchi AE, Murphy MB, Spencer J, et al, 2008 Is a priming dose of insulin necessary in a low-dose insulin protocol for the treatment of diabetic ketoacidosis? Diabetes Care 31: 2081–2085.
American Diabetes Association, 2009 Diabetes experts issue new recommendations for inpatient glycemic control – Call for systemic changes in Hospitals Nationwide. Available online. https://doi.org/www.diabetes.org/for-media/2009/diabetes-experts-issue-new-2009.html. Accessed April 5, 2011.
The NICE-SUGAR Study Investigators, 2009 Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360: 1283–1297.
Krinsley JS, 2006 Glycemic control, diabetic status, and mortality in a heterogeneous population of critically ill patients before and during the era of intensive glycemic management: six and one-half years experience at a University-Affiliated Community Hospital. Semi Thorac Cardiovasc Surg 18: 317–325.
Falciglia M, Freyberg RW, Almenoff PL, et al, 2009 Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med 37: 3001–3009.
Randy MY, Johnson DJ, Patel BM, et al, 2005 Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without Diabetes Mellitus. Mayo Clin Proc 80: 1558–1567.
Kitabchi AE, Umpierrez GE, Fisher JN, et al, 2008 Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. J Clin Endocrinol Metab 93: 1541–1552.
Umpierrez GE, Jones S, Smiley D, et al, 2009 Insulin analogs versus human insulin in the treatment of patients with diabetic ketoacidosis: a randomized controlled trial. Diabetes Care 32: 1164–1169.
Umpierrez GE, Latif K, Stoever J, et al, 2004 Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Med 117: 291–296.
Umpierrez GE, Cuervo R, Karabell A, et al, 2004 Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care 27: 1873–1878.
Della Manna T, Steinmetz L, Campos PR, et al, 2005 Subcutaneous use of a fast-acting insulin analog: An alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care 28: 1856–1861.
Peterson LN, Levi M 2002 Disorder of potassium and metabolism. In: Schrier RW (ed). Renal and electrolyte disordes, 6th edn, Lippincott Williams & Wilkins, Philadelphia; pp, 171–215.
Viallon A, Zeni F, Lafond P, et al, 1999 Does bicarbonate therapy improve the management of severe diabetic ketoacidosis? Crit Care Med 27: 2690–2693.
Adrogue HJ, Wilson H, Boyd AE 3rd, et al, 1982 Plasma acid-base patterns in diabetic ketoacidosis. N Engl J Med 307: 1603–1610.
Okuda Y, Adrogue HJ, Field JB, et al, 1996 Counterproductive effects of sodium bicarbonate in diabetic ketoacidois in childhood. J Clin Endocriniol Metab 81: 314–320.
Foster DW, McGarry JD, 1982 The metabolic derangements and treatment of diabetic ketoacidosis. N Eng J Med 309: 159–169.
Fisher JN, Kitabchi AE, 1983 A randomized study of phosphate therapy in the treatment of diabetic ketoacidosis. J Clin Endocrinol Metab 57: 177–180.
Winter RJ, Harris CJ, Phillips LS et al, 1979 Diabetic ketoacidosis: induction of hypocalcemia and hypomagnesemia by phosphate therapy. Am J Med 67: 897–900.
Kreisberg RA, 1977 Phosphorus deficiency and hypophosphatemia. Hosp Pract 12: 121–128.
Geerse DA, Bindels AJ, Kuiper MA, et al, 2010 Treatment of hypophosphatemia in the intensive care unit: a review. Crit Care 14: R147.
Shiber JR, Mattu A, 2002 Serum phosphate abnormalities in the emergency department. J Emerg Med 23: 395–400.
Freire AX, Bridges L, Umpierrez GE, et al, 2005 Admission hyperglycemia and other risk factors as predictors of hospital mortality in a medical ICU population. Chest 128: 3109–3116.
Henriksen OM, Prahl JB, Røder ME, et al, 2007 Treatment of diabetic ketoacidosis in adults in Denmark: A national survey. Diabetes Res Clin Pract 77: 113–119.
Marinac JS, Mesa L, 2000 Using a severity of illness scoring system to assess intensive care unit admissions for diabetic ketoacidosis. Crit Care Med 28: 2238–2241.
Empierrez G, Smiley D 2006 Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome. In: Fonseca VA (ed). Clinical diabetes: translating research into practice, 1st edn, Saunders Elsevier, Philadelphia; pp, 101–106.
Egol AB, Fromm RE, Guntupalli KK, et al, 1999 Guide-line for ICU admission, discharge and triage. Crit Care Med 27: 633–638.
Haringhuizen A, Tjan DHT, Grool A, et al, 2010 Fatal cerebral oedema in adult diabetic ketoacidosis. Neth J Med 68: 35–37.
Glaser NS, Wootton-Gorges Sl, Marcin JP, et al, 2004 Mechanism of cerebral edema in children with diabetic ketoacidosis. J Pediatr 145: 164–171.
Abbott NJ, 2000 Inflammatory medicators and modulation of blood brain barrier permeability. Cell Mol Neurobiol 20: 131–147.
Glaser N, 2001 Cerebral edema in children with diabetic ketoacidosis. Curr Diab Rep 1: 41–46.
Yuen N, Anderson SE, Glaser N, et al, 2008 Cerebral blood flow and cerebral edema in rats with diabetic ketoacidosis. Diabetes 57: 2588–2894.
Seewi O, Vierzig A, Roth B, et al, 2010 Symptomatic cerebral oedema during treatment of diabetic ketoacidosis: effect of adjuvant octreotide infusion. Diabetol Metab Syndr 2: 56.
Edge JA, Jakes RW, Roy Y et al, 2006 The UK case– control study of cerebral oedema complicating diabetic ketoacidosis in children. Diabetologia 49: 2002–2009.
Brun-Buisson CJ, Bonnet F, Bergeret S, et al, 1985 Re-current high-permeability pulmonary edema associated with diabetic ketoacidosis. Crit Care Med 13: 55–56.
Brandstetter RD, Tamarin FM, Washington D, et al, 1987 Occult mucous airway obstruction in diabetic ketoacidosis. Chest 91: 575–578.
Hansen LA, Prakash UB, Colby TV, 1989 Pulmonary complications in diabetes mellitus. Mayo Clin Proc 64: 791–799.
Chiasson JL, Aris-Jilwan N, Bélanger R, et al, 2003 Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Can Med Assoc J 168: 859–866.
Ashrafi M, Hashemipour M, Moadab M, et al, 2007 Ischemic intestinal necrosis in a five-year-old girl with diabetic ketoacidosis. Arch Iran Med 10: 529–531.
Wilson JF, 2010 In Clinic. Diabetic ketoacidosis. Ann Intern Med 152: ITC1–14.
Toeller M, Buyken AE, Heitkamp G, et al, 1999 Prevalence of chronic complications, metabolic control and nutritional intake in type 1 diabetes: comparison between different European regions. EURODIAB Complications Study group. Horm Metab Res 31: 680–685.
Nyenwe EA, Kitabchi A. Evidence based management of hyperglycemic emergencies in diabetes mellitus. Diabetes Res Clin Pract 2011; Oct 4 epub ahead of print
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chaithongdi, N., Subauste, J.S., Koch, C.A. et al. Diagnosis and management of hyperglycemic emergencies. Hormones 10, 250–260 (2011). https://doi.org/10.14310/horm.2002.1316
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.14310/horm.2002.1316